Search results
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 6 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 6 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Trending: Moderna's Proposed RSV Vaccine Faces Delayed FDA Review
Morningstar· 6 days ago13:53 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company said that the U.S ...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most recent filing ...
Genetics Played Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 8 hours agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
Moderna’s Promise of mRNA Undercut by New RSV Vaccine
Bloomberg· 7 days agoConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 7 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 6 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 6 days ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...